To investigate the prevalence, characteristics, and clinical significance of hearing loss as an extraintestinal manifestation (EIM) in patients with inflammatory bowel disease (IBD).
Audiologists seeing patients with IBD should be aware of a possible link between active gut disease and hearing loss; however, the observational study design means no protocol change is warranted until stronger prospective evidence is available.
Recognising hearing loss as a potential extraintestinal (outside the main organ) manifestation of IBD could prompt earlier audiological referrals from gastroenterology and expand interdisciplinary care pathways.
- 01Study published in Otology & Neurotology examines hearing loss prevalence in IBD patients.
- 02Hearing loss is identified as an extraintestinal manifestation of IBD alongside clinical predictors.
- 03Certain patient characteristics may predict who is at higher risk for IBD-related auditory involvement.
- 04Findings could support cross-specialty referral pathways between gastroenterology and audiology.
- 05Study design is observational; causation cannot be confirmed from this data alone.
Hearing loss can occur as an extraintestinal manifestation of inflammatory bowel disease.
studypartially supportedClinical predictors can identify IBD patients at higher risk of auditory involvement.
studypartially supported- PMID
- 42325155
- DOI
- 10.1097/MAO.0000000000004985.
- Journal
- Otology & Neurotology
- Publication type
- research_article
- Evidence level
- 4
- Population
- Patients with inflammatory bowel disease (Crohn's disease and/or ulcerative colitis) assessed for auditory involvement
- Intervention
- Assessment of hearing loss prevalence and clinical predictors in IBD patients
Primary outcomes
Prevalence of hearing loss in IBD patients; Clinical predictors of auditory involvement; Prognostic implications of hearing loss in IBD